Table 1 Clinical characteristics of melanoma patients (n = 47).
From: The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients
Clinical characteristics of melanoma patients (n = 47) | |
|---|---|
Average age (years) | 55 |
Sex | |
Men | 26 (55.3%) |
Women | 21 (44.7%) |
LDH concentration (first sample) | |
>upper limit of normal | 15 (31.9%) |
<upper limit of normal | 32 (68.1%) |
S100 concentration (first sample) | |
>upper limit of normal | 22 (46.8%) |
<upper limit of normal | 25 (53.2%) |
AJCC tumor stage | |
IIIC | 3 (6.4%) |
IV M1a | 5 (10.6%) |
IV M1b | 11 (23.4%) |
IV M1c | 28 (59.6%) |
Initial Treatment | |
BRAFi | 13 (27.7%) |
BRAFi+MEKi | 17 (36.2%) |
Ipilimumab | 3 (6.4%) |
Nivolumab | 6 (12.8%) |
Pembrolizumab | 8 (17,0%) |
